Argonaut Therapeutics Presents at BioTrinity 2022 Conference
Oxford, UK, 26 April 2022 – Argonaut Therapeutics, a leading developer of novel cancer agents,…
Oxford, UK, 26 April 2022 – Argonaut Therapeutics, a leading developer of novel cancer agents,…
Oxford, UK, 21 January 2021 – Argonaut Therapeutics, a leading developer of novel cancer agents,…
Oxford, UK, 1 August 2020 – Argonaut Therapeutics, a leading developer of novel cancer agents,…
Oxford, UK, March 2019 – Argonaut Therapeutics, a leading developer of novel cancer therapies, announced…